Noncoding RNA-guided recruitment of transcription factors: A prevalent but undocumented mechanism?

BioEssays

Volumn 37, Issue 9, 2015, Pages 936-941

  Lee, Nara ^a   Steitz, Joan A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Noncoding RNA; Trans acting ncRNAs; Transcription factor binding; Transcription factor recruitment

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; EPSTEIN BARR VIRUS ENCODED RNA 1; EPSTEIN BARR VIRUS ENCODED RNA 2; RIBONUCLEASE H; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX5; UNCLASSIFIED DRUG; UNTRANSLATED RNA; VIRUS PROTEIN;

ARTIFICIAL SELECTION; B LYMPHOCYTE; BASE PAIRING; BINDING SITE; CELL GROWTH; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONSENSUS SEQUENCE; DNA BASE COMPOSITION; DNA BINDING; DNA SEQUENCE; EPISOME; GENETIC CODE; GENETIC CONSERVATION; GENOMIC INSTABILITY; HETEROCHROMATIN; HOMEOBOX; HUMAN; INTERACTIONS WITH RNA; LIFE CYCLE STAGE; LYMPHOCYTE TRANSFORMATION; MOLECULAR RECOGNITION; NONHUMAN; NOTE; PHENOTYPE; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; RNA BINDING; RNA SEQUENCE; TRANSCRIPTION ELONGATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION; EPSTEIN BARR VIRUS; GENE SILENCING; GENETICS; METABOLISM;

HUMAN HERPESVIRUS 4;

GENE SILENCING; HERPESVIRUS 4, HUMAN; HUMANS; RNA, UNTRANSLATED; TRANSCRIPTION FACTORS;

EID: 84939653808     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201500060     Document Type: Note

References (50)

1. Djebali S, Davis CA, Merkel A, Dobin A, et al. 2012. Landscape of transcription in human cells. Nature 489: 101-8.
2. Guttman M, Amit I, Garber M, French C, et al. 2009. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458: 223-7.
3. Iyer MK, Niknafs YS, Malik R, Singhal U, et al. 2015. The landscape of long noncoding RNAs in the human transcriptome. Nat Genet 47: 199-208.
4. Cabili MN, Trapnell C, Goff L, Koziol M, et al. 2011. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 25: 1915-27.
5. Cech TR, Steitz JA. 2014. The noncoding RNA revolution-trashing old rules to forge new ones. Cell 157: 77-94.
6. Khalil AM, Guttman M, Huarte M, Garber M, et al. 2009. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci USA 106: 11667-72.
7. Zhao J, Sun BK, Erwin JA, Song JJ, et al. 2008. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 322: 750-6.
8. Kanhere A, Viiri K, Araujo CC, Rasaiyaah J, et al. 2010. Short RNAs are transcribed from repressed polycomb target genes and interact with polycomb repressive complex-2. Mol Cell 38: 675-88.
9. Nguyen VT, Kiss T, Michels AA, Bensaude O. 2001. 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes. Nature 414: 322-5.
10. Tsai MC, Manor O, Wan Y, Mosammaparast N, et al. 2010. Long noncoding RNA as modular scaffold of histone modification complexes. Science 329: 689-93.
11. Yang Z, Zhu Q, Luo K, Zhou Q. 2001. The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription. Nature 414: 317-22.
12. Steitz JA, Jakes K. 1975. How ribosomes select initiator regions in mRNA: base pair formation between the 3′ terminus of 16S rRNA and the mRNA during initiation of protein synthesis in Escherichia coli. Proc Natl Acad Sci USA 72: 4734-8.
13. Matthaei JH, Nirenberg MW. 1961. Characteristics and stabilization of DNAase-sensitive protein synthesis in E. coli extracts. Proc Natl Acad Sci USA 47: 1580-8.
14. Will CL, Luhrmann R. 2011. Spliceosome structure and function. Cold Spring Harb Perspect Biol 3: pii: a003707.
15. Watkins NJ, Bohnsack MT. 2012. The box C/D and H/ACA snoRNPs: key players in the modification, processing and the dynamic folding of ribosomal RNA. Wiley Interdiscip Rev RNA 3: 397-414.
16. Kim VN, Han J, Siomi MC. 2009. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10: 126-39.
17. Gilbert LA, Larson MH, Morsut L, Liu Z, et al. 2013. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154: 442-51.
18. Doudna JA, Charpentier E. 2014. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346: 1258096.
19. Holoch D, Moazed D. 2015. RNA-mediated epigenetic regulation of gene expression. Nat Rev Genet 16: 71-84.
20. Lee N, Moss WN, Yario TA, Steitz JA. 2015. EBV noncoding RNA binds nascent RNA to drive host PAX5 to viral DNA. Cell 160: 607-18.
21. Young LS, Rickinson AB. 2004. Epstein-Barr virus: 40 years on. Nat Rev Cancer 4: 757-68.
22. Delecluse HJ, Feederle R, O'Sullivan B, Taniere P. 2007. Epstein Barr virus-associated tumours: an update for the attention of the working pathologist. J Clin Pathol 60: 1358-64.
23. Lerner MR, Andrews NC, Miller G, Steitz JA. 1981. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 78: 805-9.
24. Tycowski KT, Guo YE, Lee N, Moss WN, et al. 2015. Viral noncoding RNAs: more surprises. Genes Dev 29: 567-584.
25. Fok V, Friend K, Steitz JA. 2006. Epstein-Barr virus noncoding RNAs are confined to the nucleus, whereas their partner, the human La protein, undergoes nucleocytoplasmic shuttling. J Cell Biol 173: 319-25.
26. Howe JG, Steitz JA. 1986. Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization. Proc Natl Acad Sci USA 83: 9006-10.
27. Gulley ML, Tang W. 2008. Laboratory assays for Epstein-Barr virus-related disease. J Mol Diagn 10: 279-92.
28. Yajima M, Kanda T, Takada K. 2005. Critical role of Epstein-Barr Virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation. J Virol 79: 4298-307.
29. Gregorovic G, Bosshard R, Karstegl CE, White RE, et al. 2011. Cellular gene expression that correlates with EBER expression in Epstein-Barr Virus-infected lymphoblastoid cell lines. J Virol 85: 3535-45.
30. Swaminathan S, Tomkinson B, Kieff E. 1991. Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro. Proc Natl Acad Sci USA 88: 1546-50.
31. Simon MD, Wang CI, Kharchenko PV, West JA, et al. 2011. The genomic binding sites of a noncoding RNA. Proc Natl Acad Sci USA 108: 20497-502.
32. Lee N, Pimienta G, Steitz JA. 2012. AUF1/hnRNP D is a novel protein partner of the EBER1 noncoding RNA of Epstein-Barr virus. RNA 18: 2073-82.
33. Lindahl T, Adams A, Bjursell G, Bornkamm GW, et al. 1976. Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line. J Mol Biol 102: 511-30.
34. Medvedovic J, Ebert A, Tagoh H, Busslinger M. 2011. Pax5: a master regulator of B cell development and leukemogenesis. Adv Immunol 111: 179-206.
35. Nechanitzky R, Akbas D, Scherer S, Gyory I, et al. 2013. Transcription factor EBF1 is essential for the maintenance of B cell identity and prevention of alternative fates in committed cells. Nat Immunol 14: 867-75.
36. Lacoste V, Lavergne A, de Thoisy B, Pouliquen JF, et al. 2010. Genetic diversity and molecular evolution of human and non-human primate Gammaherpesvirinae. Infect Genet Evol 10: 1-13.
37. Rivailler P, Jiang H, Cho YG, Quink C, et al. 2002. Complete nucleotide sequence of the rhesus lymphocryptovirus: genetic validation for an Epstein-Barr virus animal model. J Virol 76: 421-6.
38. Busslinger M, Urbanek P. 1995. The role of BSAP (Pax-5) in B-cell development. Curr Opin Genet Dev 5: 595-601.
39. Revilla IDR, Bilic I, Vilagos B, Tagoh H, et al. 2012. The B-cell identity factor Pax5 regulates distinct transcriptional programmes in early and late B lymphopoiesis. EMBO J 31: 3130-46.
40. Lewis EB. 1978. A gene complex controlling segmentation in Drosophila. Nature 276: 565-70.
41. Mann RS, Lelli KM, Joshi R. 2009. Hox specificity unique roles for cofactors and collaborators. Curr Top Dev Biol 88: 63-101.
42. Chan SK, Jaffe L, Capovilla M, Botas J, et al. 1994. The DNA binding specificity of Ultrabithorax is modulated by cooperative interactions with extradenticle, another homeoprotein. Cell 78: 603-15.
43. Chang CP, Shen WF, Rozenfeld S, Lawrence HJ, et al. 1995. Pbx proteins display hexapeptide-dependent cooperative DNA binding with a subset of Hox proteins. Genes Dev 9: 663-74.
44. Raab-Traub N, Flynn K. 1986. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47: 883-9.
45. Arvey A, Tempera I, Tsai K, Chen HS, et al. 2012. An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions. Cell Host Microbe 12: 233-45.
46. McManus S, Ebert A, Salvagiotto G, Medvedovic J, et al. 2011. The transcription factor Pax5 regulates its target genes by recruiting chromatin-modifying proteins in committed B cells. EMBO J 30: 2388-404.
47. Brown NA, Liu CR, Wang YF, Garcia CR. 1988. B-cell lymphoproliferation and lymphomagenesis are associated with clonotypic intracellular terminal regions of the Epstein-Barr virus. J Virol 62: 962-9.
48. Sugden B, Phelps M, Domoradzki J. 1979. Epstein-Barr virus DNA is amplified in transformed lymphocytes. J Virol 31: 590-5.
49. Bzymek M, Lovett ST. 2001. Instability of repetitive DNA sequences: the role of replication in multiple mechanisms. Proc Natl Acad Sci USA 98: 8319-25.
50. Bulut-Karslioglu A, Perrera V, Scaranaro M, de la Rosa-Velazquez IA, et al. 2012. A transcription factor-based mechanism for mouse heterochromatin formation. Nat Struct Mol Biol 19: 1023-30.